Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 8Pancreatic Neoplasms 4Rectal Neoplasms 3Colonic Neoplasms 2Stomach Neoplasms 1Sarcoma 1Neoplasm Metastasis 1Esophageal Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1

Interventions

Magnetic Resonance Spectroscopy 4Therapeutics 3Immunoenzyme Techniques 3Early Intervention, Educational 3Cyclophosphamide 3Biopsy 3saponin QA-21V1 2exemestane 2Vorinostat 2Standard of Care 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2Letrozole 2Immunologic Techniques 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Flow Cytometry 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Bevacizumab 2Anastrozole 2Acupuncture Therapy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2pegfilgrastim 1iso-sulfan blue 1alovudine 1Zoledronic Acid 1Trastuzumab 1Tomography, Emission-Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms, Male × Irinotecan × Clear all
NCT01939483 2014-10-08

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

University of California, Irvine

Phase NA Withdrawn
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡